We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
Cap. Flow
+$454M
Cap. Flow %
6.54%
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$34.9M
2
SBAC icon
SBA Communications
SBAC
+$31.5M
3
LII icon
Lennox International
LII
+$29.1M
4
MCK icon
McKesson
MCK
+$24.8M
5
CABO icon
Cable One
CABO
+$23.9M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$55.8M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$52.7M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$42.5M
4
ISRG icon
Intuitive Surgical
ISRG
+$35.5M
5
XLNX
Xilinx Inc
XLNX
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 19.87%
2 Financials 16.58%
3 Consumer Discretionary 13.8%
4 Industrials 12.36%
5 Healthcare 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRD.B icon
901
Crawford & Co Class B
CRD.B
$492M
$198K ﹤0.01%
21,690
+1,400
+7% +$13.6K
ICAD
902
DELISTED
iCAD Inc
ICAD
$195K ﹤0.01%
37,714
-22,054
-37% -$107K
FTSI
903
DELISTED
FTS International, Inc. Common Stock
FTSI
$192K ﹤0.01%
960
+45
+5% +$8.05K
NATR icon
904
Nature's Sunshine
NATR
$366M
$189K ﹤0.01%
20,398
– –
ISBC
905
DELISTED
Investors Bancorp, Inc.
ISBC
$188K ﹤0.01%
15,900
+1,500
+10% +$18.1K
LRMR icon
906
Larimar Therapeutics
LRMR
$400M
$183K ﹤0.01%
5,578
+1,434
+35% +$73.5K
DGICA icon
907
Donegal Group Class A
DGICA
$705M
$177K ﹤0.01%
13,163
-1,300
-9% -$17.5K
ALSK
908
DELISTED
Alaska Communications Systems
ALSK
$173K ﹤0.01%
90,273
-10,768
-11% -$19.6K
MACK
909
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$169K ﹤0.01%
30,885
-22,758
-42% -$105K
BFX
910
DELISTED
BowFlex Inc.
BFX
$168K ﹤0.01%
30,177
-44,300
-59% -$343K
SYNC
911
DELISTED
Synacor, Inc.
SYNC
$168K ﹤0.01%
106,882
– –
NH
912
DELISTED
NantHealth, Inc
NH
$164K ﹤0.01%
11,902
+2,288
+24% +$26.5K
CMRX
913
DELISTED
Chimerix, Inc.
CMRX
$162K ﹤0.01%
76,987
-172,812
-69% -$394K
DRRX
914
DELISTED
DURECT Corp
DRRX
$161K ﹤0.01%
25,682
-12,615
-33% -$85.1K
SHBI icon
915
Shore Bancshares
SHBI
$800M
$159K ﹤0.01%
10,686
– –
MGI
916
DELISTED
MoneyGram International, Inc. New
MGI
$159K ﹤0.01%
77,900
-1,800
-2% -$4.11K
HIL
917
DELISTED
Hill International, Inc. Common Stock
HIL
$158K ﹤0.01%
+53,957
New +$173K
VOXX
918
DELISTED
VOXX International Corporation Class A
VOXX
$154K ﹤0.01%
33,383
+13,000
+64% +$63.6K
TGH
919
DELISTED
Textainer Group Holdings limited
TGH
$150K ﹤0.01%
+15,507
New +$184K
DXLG icon
920
Destination XL Group
DXLG
$34.3M
$149K ﹤0.01%
60,851
-26,479
-30% -$66.3K
SYRS
921
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$149K ﹤0.01%
1,628
-8,618
-84% -$600K
OSG
922
DELISTED
Overseas Shipholding Group Inc.
OSG
$149K ﹤0.01%
65,139
-33,900
-34% -$67.6K
ENT
923
DELISTED
Global Eagle Entertainment Inc.
ENT
$148K ﹤0.01%
8,344
+4,483
+116% +$255K
CMT icon
924
Core Molding Technologies
CMT
$210M
$128K ﹤0.01%
+17,338
New +$137K
AR icon
925
Antero Resources
AR
$10.7B
$119K ﹤0.01%
13,500
-2,900
-18% -$27.4K
35 36
37
38 39

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q1 2019 Portfolio in Review

As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.

  • Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
  • Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
  • Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
  • Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
  • Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
  • Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
  • Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.